申请人:[en]SUTRO BIOPHARMA, INC.
公开号:WO2023239675A1
公开(公告)日:2023-12-14
The present disclosure is related to STING agonists, pharmaceutical compositions thereof, and the use of the agonists and pharmaceutical compositions to induce a STING-mediated immune response and/or to treat diseases and disorders mediated by STING, such as cellular proliferative disorders, including, but not limited to, cancer.